SNOA
NASDAQ
$1.09
Sonoma Pharmaceuticals Inc (SNOA)
Sonoma Pharmaceuticals, Inc., develops and produces stabilized hypochlorous acid (HOCl) products for various applications, including wound care, animal health care, eye care, oral care, and dermatological conditions in the United States and internationally. The company is headquartered in Woodstock, Georgia.
Sector:
Healthcare
Target: $12 (+1000.92%)
Market Cap
$3.55M
Price Chart
Valuation
Market Cap$3.55M
Forward P/E46.08
PEG1.08
P/S0.20
P/B1.04
Profitability
Total Revenue (TTM)$18M
Gross Profit (TTM)$6.76M
EBITDA-$3.79M
Profit Margin-18.8%
Operating Margin-15.6%
EPS-$2.03
Growth & Risk
EPS 5Y CAGR-49.84%
Revenue 5Y CAGR-3.02%
FCF 5Y CAGR-3.94%
Sharpe Ratio-0.63